Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Borchers

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Aktuelle Urologie|April 5, 2023
[Why outpatient surgery does not work in hospitals - or medical practices - as yet]Björn G Volkmer, Daniela Schultz-Lampel, Thomas Speck, et al.
Urologie (Heidelberg, Germany)|October 31, 2025
[Environmental sustainability in urology]Bernd Wullich, Holger Borchers, Christian Eggersmann, et al.
Urology|February 15, 2005
Fecal incontinence after radical perineal prostatectomy: a prospective studyRuth Kirschner-Hermanns, Holger Borchers, Thorsten Reineke, et al.
Urologia Internationalis|April 8, 2006
Erectile function after non-nerve-sparing radical prostatectomy: fact or fiction?Holger Borchers, Bernhard Brehmer, Ruth Kirschner-Hermanns, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 2006
Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancerMichael Pinkawa, Bernd Gagel, Marc Dieter Piroth, et al.
Clinical Chemistry|August 21, 2003
Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cellsDenis Schamhart, Johannes Swinnen, Karl-Heinz Kurth, et al.
European Urology|July 19, 2011
Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trialsFrank Peinemann, Ulrich Grouven, Carmen Bartel, et al.
Urology|June 30, 2006
Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancerMichael Pinkawa, Karin Fischedick, Bernd Gagel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2007
Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seedsMichael Pinkawa, Branka Asadpour, Bernd Gagel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2006
Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parametersMichael Pinkawa, Karin Fischedick, Marc D Piroth, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Aktuelle Urologie|April 5, 2023
[Why outpatient surgery does not work in hospitals - or medical practices - as yet]Björn G Volkmer, Daniela Schultz-Lampel, Thomas Speck, et al.
Urologie (Heidelberg, Germany)|October 31, 2025
[Environmental sustainability in urology]Bernd Wullich, Holger Borchers, Christian Eggersmann, et al.
Urology|February 15, 2005
Fecal incontinence after radical perineal prostatectomy: a prospective studyRuth Kirschner-Hermanns, Holger Borchers, Thorsten Reineke, et al.
Urologia Internationalis|April 8, 2006
Erectile function after non-nerve-sparing radical prostatectomy: fact or fiction?Holger Borchers, Bernhard Brehmer, Ruth Kirschner-Hermanns, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 2006
Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancerMichael Pinkawa, Bernd Gagel, Marc Dieter Piroth, et al.
Clinical Chemistry|August 21, 2003
Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cellsDenis Schamhart, Johannes Swinnen, Karl-Heinz Kurth, et al.
European Urology|July 19, 2011
Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trialsFrank Peinemann, Ulrich Grouven, Carmen Bartel, et al.
Urology|June 30, 2006
Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancerMichael Pinkawa, Karin Fischedick, Bernd Gagel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2007
Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seedsMichael Pinkawa, Branka Asadpour, Bernd Gagel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2006
Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parametersMichael Pinkawa, Karin Fischedick, Marc D Piroth, et al.
Pageof 3